WHO Response to STREAM Stage 1 Preliminary Results

“WHO issues a position statement on the continued use of the shorter MDR-TB regimen following an expedited review of the STREAM Stage 1 preliminary result.

In response to several queries to the World Health Organization (WHO) from member states and other major stakeholders on the continued use of the shorter regimen for multidrug-resistant TB (MDR-TB), following the release of preliminary results of the STREAM Stage 1 phase III randomized controlled trial, the WHO Global Tuberculosis Programme completed an expedited review of data provided by the STREAM trial consortium in January 2018.”

Click here to read the position statement.

Click here to read the results of the trial.